Evidence map›Paper›PMID 32915806›Full record

ArticlePloS one2020

Neutrophil count in sputum is associated with increased sputum glucose and sputum L-lactate in cystic fibrosis.

Bibi Uhre Nielsen, Mette Kolpen, Peter Østrup Jensen, Terese Katzenstein, Tacjana Pressler, Christian Ritz, Inger Hee Mabuza Mathiesen, Daniel Faurholt-Jepsen

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Increased sputum lactate during oral glucose tolerance test in cystic fibrosis.APMIS : acta pathologica, microbiologica, et immunologica Scandinavica · 2022
    Article
  6. Biofilm Formation in Methicillin-ResistantFrontiers in microbiology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Bibi Uhre NielsenCystic Fibrosis Centre Copenhagen, Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0003-0622-5262
Mette KolpenDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.ORCID 0000-0001-5575-0384
Peter Østrup JensenDepartment of Clinical Microbiology, Rigshospitalet, Copenhagen, Denmark.
Terese KatzensteinCystic Fibrosis Centre Copenhagen, Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Tacjana PresslerCystic Fibrosis Centre Copenhagen, Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Christian RitzDepartment of Nutrition, Exercise and Sports, University of Copenhagen, Frederiksberg, Denmark.
Inger Hee Mabuza MathiesenCystic Fibrosis Centre Copenhagen, Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Daniel Faurholt-JepsenCystic Fibrosis Centre Copenhagen, Department of Infectious Diseases, Rigshospitalet, Copenhagen, Denmark.
Rigshospitalet · DKUniversity of Copenhagen · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundMarkers of lung inflammation measured directly in expectorated sputum have the potential of improving the timing of antibiotic treatment in cystic fibrosis (CF). L-Lactate might be a marker of inflammation, as it is produced from glucose by polymorphonuclear neutrophils (PMNs) in CF lungs. We aimed to investigate changes in and associations between PMNs, glucose and L-lactate in sputum during antibiotic treatment. In addition, the effect of hemoglobin A1c and plasma glucose on these biomarkers were investigated.

methodsWe sampled non-induced sputum at day 0, 7, 14 and 42 in 27 chronically infected CF patients electively treated with 14 days of intravenous antibiotic. To analyze sputum samples, we used flowcytometry to count PMNs and colorimetric assays to estimate lactate and glucose.

resultsNo changes in levels of PMNs, glucose and lactate were detected in sputum during the antibiotic treatment. Sputum PMNs were positively associated with both glucose (log coefficient = 0.20, p = 0.01) and L-lactate (log coefficient = 0.34, p<0.001). In multivariate analyses, hemoglobin A1c was negatively associated with sputum PMNs (log coefficient = -1.68, p<0.001) and plasma glucose was negatively associated with sputum glucose (log coefficient = -0.09, p = 0.02).

conclusionsIn CF sputum PMNs, glucose and lactate were unchanged during elective antibiotic treatment. However, sputum PMNs were associated with both sputum glucose and sputum lactate. Surprisingly, hyperglycemia seemed to be associated with less PMNs infiltration and less glucose in CF sputum.

Indexed as

AdultAgedAnti-Bacterial AgentsBiomarkersBlood GlucoseCystic FibrosisFemaleGlucoseGlycated HemoglobinHumansInjections, IntravenousLactic AcidLeukocyte CountMaleMultivariate AnalysisNeutrophilsAnti-Bacterial AgentsBiomarkersBlood GlucoseGlucoseGlycated HemoglobinLactic Acid

Identifiers

PMID32915806
PMCPMC7485830
OpenAlexW3085448923

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.